“Cell Therapy: An Emerging Drug Class” Biju Parekkadan, PhD Assistant Professor of Surgery Harvard Medical...
Thomas G. Christensen
Degree(s) - B.S., Ph.D.
Academic Title - Associate Professor
B.S. Rutgers University
Ph.D. University of Vermont
Research Interests -
- Quantitative image analysis of fibrotic lung abnormalities and their amelioration by drug intervention.
- Development of sensitive immunocytochemical methods to differentiate among the various types of amyloidosis.
Recent Publications -
Larson DL, TG Christensen, GD Sagar, EC Beyer. TGF-beta1 induces an accumulation of connexin43 in a lysosomal compartment in endothelial cells. Endothelium 2001; 8:255-60.
Izbicki G, MJ Segel, TG Christensen, MW Conner, R Breuer. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002; 83 (3):111-9.
Segel MJ, G Izbicki, PY Cohen, R Or, TG Christensen, SB Wallach-Dayan, R Breuer. Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1255-L1262.
Segel MJ, R Aqeilan, K Zilka, H Lorberboum-Galski, SB Wallach-Dayan, MW Conner, TG Christensen, R Breuer. Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury. Int J Exp Path 2005; 86: 279-88.
Shapira OM, BR Eskenazi, E Anter, L Joseph, TG Christensen, CT Hunter, HL Lazar, JA Vita, RJ Shemin, JF Keaney Jr. Endoscopic versus conventional radial artery harvest for coronary artery bypass grafting: Functional and histological assessment of the conduit. J Thoracic Cardiovasc Surg, 2006; 131:388-94.
- Telephone – 617-414-5060
- Email – firstname.lastname@example.org